Sunday, December 28, 2025

Impressive results with long COVID pacing trial

A pacing rehabilitation programme that helps people with long COVID reduce their symptoms and increase activity levels has shown “impressive” results, say scientists.

Vaccination reduces the risk of severe COVID-19 infection

However, adults who are frail, living in areas of high deprivation or have unhealthy lifestyles are more at risk of COVID-19 infection and getting ill, despite being vaccinated, compared to other vaccinated people.

New strategies needed for marketing in the New Normal

Marketing in the New Normal Press Release: University of Canterbury Join a panel of local...

OUHK sets aside more than HKD 20 million for a one-off special relief fund

OUHK sets aside more than HKD 20 million for a one-off special relief fund to subsidize all students studying at the University in 2020/21 academic year...

Watch: Using AI to protect air passengers in a pandemic

The COVID-19 pandemic has created an unparalleled crisis for the airline industry: International and domestic air travel has slowed considerably...

Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

University of Bristol students launch international charity scheme

A scheme set up by five University of Bristol undergraduates has begun to support charities across the globe during the COVID-19 pandemic.

University of Canterbury staff delivering care for students with Covid-19

University of Canterbury (UC) staff volunteers have been busy making welfare calls, distributing care packs and delivering groceries to students isolating with Covid-19.

University of Alberta lab reveals how a much-needed oral antiviral drug confuses the replication...

A University of Alberta virology lab has uncovered how an oral antiviral drug works to attack the SARS-CoV-2 virus, in findings published May 10 in the Journal of Biological Chemistry.

First step to curb COVID vaccine misinformation is finding out who is most vulnerable

The success of Australia’s COVID-19 vaccine rollout will depend on everyone’s willingness to receive it. But experts have warned vaccine misinformation online puts Australia’s communities at risk...
- Advertisement -